Research Articleposted 2025-11-17 05:32:16
Design, synthesis, anticancer activity, bioimaging, and molecular docking of novel fluorescent isatin derivatives
Merve İnel, Ayse Yildirim, Mustafa Yilmaz, Bahadir Ozturk
Under Revision
at
Research Articleposted 2025-11-10 16:12:58
First-line treatments for metastatic non-small-cell lung cancer with Sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis
紫璇 张, Kehui Meng, Meiyu Wu, Andong Li, Yangke Yi, Chaohao Shi, xiaomin Wan, and 2 more authors
Under Review
at
Research Articleposted 2025-10-06 09:18:34
Tagraxofusp, a first-in-class CD123-targeted anticancer agent: A pharmacovigilance study based on the FAERS database
Chunyong Xia, Ya Gan, Jie Liu
Under Review
at
Short Reportposted 2025-07-22 09:01:26
Synergistic combination of the beta-3 antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cells
Arianna Bandini°, Letizia Biso°, Maria Cristina Viaggi, Maria Carla Pardini, Paola Orlandi, Marco Carli, Marta Banchi, and 3 more authors
Published
at
Research Articleposted 2025-07-02 06:12:46
Clinical Potential of Antibody–Drug Conjugates in Early-Phase Clinical Trials for Late-Line Treatment of Advanced Solid Tumors
Ippei Miyamoto, Takahiro Kogawa, Kana Kurokawa, Eriko Miyawaki, Yohei Arihara, Shota Fukuoka, Yukinori Ozaki, and 8 more authors
Published
at
Research Articleposted 2024-12-18 17:57:17
RMX1002 as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors: a phase I dose-escalation and expansion study
Dan Liu, Jifang Gong, Jian Zhang, Yongqian Shu, Hao Wu, Tianshu Liu, Yanhua Xu, and 4 more authors
Published
at
Research Articleposted 2024-11-18 10:54:04
The up-regulated expression level of deubiquitinating enzyme USP46 induces the apoptosis of A549 cells by TRAF6
Xuan Zhao, Yanan Li, Dandan Gu, Xiaoru Wang, Guangxin Han, Yasen Yao, Limei Ren, and 3 more authors
Published
at
Research Articleposted 2024-07-15 23:37:03
Preclinical to Clinical Translation of Antibody Drug Conjugates Using a Quantitative Systems Pharmacology (QSP) Model: A Case Study with Disitamab Vedotin
Qiaoning Li, Ling Wang, Baiyang Wu, Xinting Ma, Guorui Zhao, Zhihao Liu, Juncheng Wang, and 2 more authors
Under Review
at
Research Articleposted 2024-04-30 22:08:49
A novel recombinant adenovirus expressing apoptin and MEL genes kills hepatocellular carcinoma cells and inhibits the growth and metastasis of ectopic tumors
Jingqiao Wu, Zhaoyu Lan, Xin Li, Jinling He, Dongchao Zhang, Tianming Jin
Under Review
at
Research Articleposted 2024-04-29 12:26:17
Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision Oncology
Shannon S. Stockton, G. Dan Ayers, Cody Lee, Heather Laferriere, Satya Das, Jordan Berlin
Published
at